88 related articles for article (PubMed ID: 16596208)
1. Relationships between dynamic contrast-enhanced MRI findings and pattern of invasion for tongue carcinoma.
Ariyoshi Y; Shimahara M
Oncol Rep; 2006 May; 15(5):1339-43. PubMed ID: 16596208
[TBL] [Abstract][Full Text] [Related]
2. Fat-suppressed dynamic and delayed gadolinium-enhanced volumetric interpolated breath-hold magnetic resonance imaging of cholangiocarcinoma.
Leyendecker JR; Gakhal M; Elsayes KM; McDermott R; Narra VR; Brown JJ
J Comput Assist Tomogr; 2008; 32(2):178-84. PubMed ID: 18379298
[TBL] [Abstract][Full Text] [Related]
3. 3D dynamic contrast-enhanced MRI of rectal carcinoma at 3T: correlation with microvascular density and vascular endothelial growth factor markers of tumor angiogenesis.
Zhang XM; Yu D; Zhang HL; Dai Y; Bi D; Liu Z; Prince MR; Li C
J Magn Reson Imaging; 2008 Jun; 27(6):1309-16. PubMed ID: 18504761
[TBL] [Abstract][Full Text] [Related]
4. Two different types of ring-like enhancement on dynamic MR imaging in breast cancer: correlation with the histopathologic findings.
Kobayashi M; Kawashima H; Matsui O; Zen Y; Suzuki M; Inokuchi M; Noguchi M; Ohta T
J Magn Reson Imaging; 2008 Dec; 28(6):1435-43. PubMed ID: 19025952
[TBL] [Abstract][Full Text] [Related]
5. Assessment of carcinoma in the sublingual region based on magnetic resonance imaging.
Asaumi J; Shigehara H; Konouchi H; Yanagi Y; Hisatomi M; Matsuzaki H; Kishi K
Oncol Rep; 2002; 9(6):1283-7. PubMed ID: 12375035
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
7. Prediction of early response to radiotherapy of uterine carcinoma with dynamic contrast-enhanced MR imaging using pixel analysis of MR perfusion imaging.
Takayama Y; Ohno T; Kishimoto R; Kato S; Yoneyama R; Kandatsu S; Tsujii H; Obata T
Magn Reson Imaging; 2009 Apr; 27(3):370-6. PubMed ID: 18768283
[TBL] [Abstract][Full Text] [Related]
8. Analysis of mice tumor models using dynamic MRI data and a dedicated software platform*.
Alfke H; Kohle S; Maurer E; Celik I; Rascher-Friesenhausen R; Behrens S; Heverhagen JT; Peitgen HO; Klose KJ
Rofo; 2004 Sep; 176(9):1226-31. PubMed ID: 15346255
[TBL] [Abstract][Full Text] [Related]
9. Assessment of ameloblastomas using MRI and dynamic contrast-enhanced MRI.
Asaumi J; Hisatomi M; Yanagi Y; Matsuzaki H; Choi YS; Kawai N; Konouchi H; Kishi K
Eur J Radiol; 2005 Oct; 56(1):25-30. PubMed ID: 16168260
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of chest wall invasion by lung cancer: useful criteria for exclusion of the possibility of chest wall invasion with MR imaging.
Shiotani S; Sugimura K; Sugihara M; Kawamitsu H; Yamauchi M; Yoshida M; Kushima T; Kinoshita T; Endoh H; Nakayama H; Kajitani M; Wada M
Radiat Med; 2000; 18(5):283-90. PubMed ID: 11128398
[TBL] [Abstract][Full Text] [Related]
11. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
Mendichovszky IA; Cutajar M; Gordon I
Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
[TBL] [Abstract][Full Text] [Related]
12. Tracer kinetics analysis of dynamic contrast-enhanced CT and MR data in patients with squamous cell carcinoma of the upper aerodigestive tract: comparison of the results.
Bisdas S; Baghi M; Wagenblast J; Bisdas T; Thng CH; Mack MG; Koh TS; Ernemann U
Clin Physiol Funct Imaging; 2009 Sep; 29(5):339-46. PubMed ID: 19473200
[TBL] [Abstract][Full Text] [Related]
13. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer.
Zahra MA; Tan LT; Priest AN; Graves MJ; Arends M; Crawford RA; Brenton JD; Lomas DJ; Sala E
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):766-73. PubMed ID: 19019563
[TBL] [Abstract][Full Text] [Related]
14. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
[TBL] [Abstract][Full Text] [Related]
15. Assessment of tumor microcirculation with dynamic contrast-enhanced MRI in patients with esophageal cancer: initial experience.
Oberholzer K; Pohlmann A; Schreiber W; Mildenberger P; Kunz P; Schmidberger H; Junginger T; Düber C
J Magn Reson Imaging; 2008 Jun; 27(6):1296-301. PubMed ID: 18504749
[TBL] [Abstract][Full Text] [Related]
16. [Estimation of diffuse bone marrow infiltration of the spine in multiple myeloma: correlation of MRT with histological results].
Schmidt GP; Baur A; Stäbler A; Schoenberg SO; Steinborn M; Baltin V; Reiser MF
Rofo; 2005 May; 177(5):745-50. PubMed ID: 15871089
[TBL] [Abstract][Full Text] [Related]
17. MR imaging of hepatocellular carcinoma: relationship between lesion size and imaging findings, including signal intensity and dynamic enhancement patterns.
van den Bos IC; Hussain SM; Dwarkasing RS; Hop WC; Zondervan PE; de Man RA; IJzermans JN; Walker CW; Krestin GP
J Magn Reson Imaging; 2007 Dec; 26(6):1548-55. PubMed ID: 17968956
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the three-time-point method for diagnosis of breast lesions in contrast-enhanced MR mammography.
Hauth EA; Stockamp C; Maderwald S; Mühler A; Kimmig R; Jaeger H; Barkhausen J; Forsting M
Clin Imaging; 2006; 30(3):160-5. PubMed ID: 16632149
[TBL] [Abstract][Full Text] [Related]
19. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA.
Tamada T; Ito K; Sone T; Yamamoto A; Yoshida K; Kakuba K; Tanimoto D; Higashi H; Yamashita T
J Magn Reson Imaging; 2009 Mar; 29(3):636-40. PubMed ID: 19243060
[TBL] [Abstract][Full Text] [Related]
20. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
Lowry M; Zelhof B; Liney GP; Gibbs P; Pickles MD; Turnbull LW
Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
